PATENT CLAIM ANALYSIS

Application Number: 15949750
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "333000"]

Abstract:
Provided are compounds and pharmaceutical compositions useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound or pharmaceutical composition described herein.

Claim (Index 66):
The pharmaceutical composition of  claim 46  wherein the pharmaceutical composition comprises, about 30% w/w of compound 1, or a pharmaceutically acceptable salt thereof, about 30% w/w of hypromellose acetate succinate (HPMCAS), about 29.5% w/w of microcrystalline cellulose, about 6% w/w croscarmellose sodium, about 1% w/w sodium lauryl sulfate, about 2% w/w colloidal silicon dioxide, and about 1.5% w/w of magnesium stearate.

Metadata:
- Claim Count in Document: 83.0
- Percentile: 91.0
- Lexical Diversity: 1.19231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15125880', '15767822', '15238161', '13452136', '15589615']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7252957444889265
- 35 USC 102 Novelty (BERT): 0.5583638438518018
- Combined Prediction Score: 0.7086025544252141
- Mean Citation Score: 286.76045
- Max Citation Score: 454.82306
- Similarity Product: 258.5963154656839

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test